Psychedelics Awakn set to research ketamine for alcohol use disorder The trial will be held at 7 NHS sites in the U.K. with the NIHR funding 66% of the cost Rowan DunneDecember 14, 2022
News ASKP3 Patient Portal to offer accurate fact-based info on ketamine Platform is intended to educate patients and medical providers on benefits of ketamine for treating pain and mood disorders Rowan DunneOctober 14, 2022
Psychedelics Choose Ketamine now offering at-home treatments in several states Company intends to provide ketamine therapy at a much lower price than a visit to the clinic would cost Rowan DunneOctober 4, 2022
Canada Numinus launches ketamine-assisted therapy in Toronto Neurology Centre of Toronto in Forest Hill expands its therapy catalogue Rowan DunneSeptember 21, 2022